It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
DAKAR, Senegal (AP) — More than 10,000 people have been infected with Ebola and nearly half of them have died, according to figures released Saturday by the World Health Organization, as the outbreak continues to spread.
The Ebola epidemic in West Africa is the largest ever outbreak of the disease with a rapidly rising death toll in Guinea, Liberia and Sierra Leone. There have also been cases in three other West African countries, Spain and the United States.
WHO: Number of Ebola-linked cases passes 10,000
Because that's how it works. The more people who are infected, the more become infected. That's sort of epidemiology 101.
Why the sudden exponential spread.
Ebola vaccine trials are to start in west Africa in December, a month earlier than planned, and hundreds of thousands of doses will be available by mid-2015, the World Health Organisation says.
A high-level meeting of government representatives, including donor countries and those affected, together with vaccine manufacturers, has decided to push ahead with unprecedented speed, even though the early data on safety and the immune system response to the vaccines will not all be in.
The first vaccinations of health workers and others at high risk, including burial teams, are likely to take place in Liberia, with Sierra Leone not far behind. In the Liberian trial, the vaccines will be tested against placebo – some health workers will get the Ebola shot, while others will be given a vaccine that is protective against another disease, such as measles. The selection will be random and blinded, so that neither volunteers nor doctors know who has been given which vaccine until the trial ends.
www.theguardian.com...
originally posted by: masqua
a reply to: onequestion
What vaccines? They have yet to be produced.
Ebola vaccine trials are to start in west Africa in December, a month earlier than planned, and hundreds of thousands of doses will be available by mid-2015, the World Health Organisation says.
A high-level meeting of government representatives, including donor countries and those affected, together with vaccine manufacturers, has decided to push ahead with unprecedented speed, even though the early data on safety and the immune system response to the vaccines will not all be in.
The first vaccinations of health workers and others at high risk, including burial teams, are likely to take place in Liberia, with Sierra Leone not far behind. In the Liberian trial, the vaccines will be tested against placebo – some health workers will get the Ebola shot, while others will be given a vaccine that is protective against another disease, such as measles. The selection will be random and blinded, so that neither volunteers nor doctors know who has been given which vaccine until the trial ends.
www.theguardian.com...
originally posted by: onequestion
Oh no!
Quick everyone buy super expensive vaccines!
I am a bit curious why the mortality rate thrown around is so high. From what I read, "5,488 cases and 2,945 deaths having been laboratory confirmed"
The final piece of the puzzle is how epidemics work. Epidemiologists talk of “r nought”, R0, the most basic epidemiological number. It is, simply put, the number of new infections each ill person generates. If it is less than 1, R0 < 1, the infection will tend to die out. Each ill person is not replaced by another ill person. Bigger than 1, every ill person infects multiple people, it will grow exponentially.
It’s like that game: put a single grain of rice into the first chess block. Double it in the next one: two grains of rice. Double it again: four grains. There are 64 blocks in a chess board. Once you go through all 64, you will have 18,446,744,073,709,551,616 grains of rice or about 636,094,623,231,363 pounds. As in trillions.
That’s how exponential math works. It gets big, very quickly.
Health Minister Rona Ambrose said that 20 vials of the vaccine will be tested on 40 healthy volunteers at the Walter Reed Army Institute of Research in Maryland.
The trial, known as a Phase 1 trial, is designed to determine if VSV-EBOV is safe for human use. It is also designed to determine the right dosage for humans and to look out for any side effects.
When will the results of the trial be known?
Dr. Gregory Taylor, Canada's Chief Public Health Officer, said results from the trial could be available by December.
If those results show that the vaccine is successful, the next step would be to test it in a larger group, including people who have had direct contact with Ebola patients in West Africa.
Will there be other trials for the vaccine?
NewLink Genetics, the U.S. firm that holds the licence for the vaccine, said earlier in October that there will be at least five clinical trials for VSV-EBOV. These will take place in the U.S., Germany, Switzerland and an African country not currently affected by the outbreak.
Read more: www.ctvnews.ca...